Lupin gets USFDA nod for opioid analgesic tablets

The company has received final approval from USFDA to market its Oxycodone Hydrochloride tablets USP, in the strengths of 5 mg, 10 mg, 15 mg, 20 mg and 30 mg, Lupin said.
Source: The Economic Times Healthcare and Biotech News - Category: Pharmaceuticals Source Type: news